Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Healthcare Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

Bullboard (TSXV:HEM)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by sdhakaon Jul 16, 2024 4:33pm

Hemostemix went up 22% wow as of july 15

Hemostemix went up 22% wow as of july 15. Can this be linked to their recent announcement relating to trademark granted by Switzerland and Interest Payment?   I follow this weekly commentary ...more  
143
Post by martelon Jul 15, 2024 11:41am

Hemostemix: Pioneering Autologous Cell Therapies

Hemostemix ($HEM) leverages its advanced technology platform to develop autologous cell therapies, focusing on treatments for vascular diseases. With a 52-week range of $0.175 to $0.035, the company ...more  
125
Post by sdhakaon Jun 04, 2024 2:35pm

Hemostemix Announces Partnership and Funding

Hemostemix Announces Partnership and Funding for ACP-01 Manufacturing Hemostemix Inc. (HEM) announced a strategic manufacturing partnership with CytoImmune Therapeutics, a private company ...more  
162
Comment by JocetooBadon Apr 30, 2024 3:43pm

RE:Hemostemix's Share Growth: A Sign of Therapeutic Impact

If I understand your post well, you're saying that a 77% drop in share price is highlighting the positive impact + potential of this company? I'm not following you. The drop in share price is ...more  
167
Discussion
Post by lelianicruzon Apr 25, 2024 10:34am

Hemostemix's Share Growth: A Sign of Therapeutic Impact

Hemostemix's share price has shown a dynamic 52-week high/low range of $0.175 to $0.04. This fluctuation not only underscores the company's growth potential but also highlights the ...more  
216
Discussion
Comment by JocetooBadon Feb 16, 2024 11:54am

RE:Ah, what will the New Year bring?

Dude, I'm in the same boat. Will a government grant save the day on the very last minute? Indeed 2024 will tell.
135
Discussion
Post by Dudeforeveron Dec 07, 2023 4:52pm

Ah, what will the New Year bring?

2024 will either be HEM's last year, or else one of their many claims actually proves to have substance.  Thomas has drained his cup of credibility.  Raising money is going to be almost ...more  
496
Discussion
Comment by Budamanon Oct 31, 2023 7:41pm

RE:$HEM experience is very bad

Same person, multiple new accounts, and all of them full of negativity, designed to try and get people to sell.  I was waiting for the wanna be trolls to reappear with this stock, and now here ...more  
253
Discussion
Post by Gefele1424on Oct 31, 2023 11:35am

$HEM experience is very bad

The company's financial statements show declining revenue; the company is not keeping up with industry trends. In my experience, this company is totally scammy.
165
Discussion
Post by hexekayon Oct 31, 2023 9:59am

Dark Days for $HEM: Shareholders Left Empty-Handed as Stock

$HEM's stock as a beacon of hope now themselves in the dark as the company's fortunes crumble. The market value of $HEM's stock has withered, leaving shareholders with little to show for ...more  
189
Post by Williammaxon Oct 31, 2023 8:44am

$HEM's Stock Fails to Deliver as Services Struggle.

$HEM's stock, which was once a beacon of hope among penny stocks, has lost its shine as the company's services falter, causing a drop in its market value. $HEM's stock has been a ...more  
158
Post by Marcos7on Oct 30, 2023 11:59am

Bad experience with $HEM .

I came to notice that the stock is performing very bad and the financial condition shows how the investors are going to suffer . I lost my money by trusting this kind of stock . Never suggest this to ...more  
184
Post by Carlos777on Oct 30, 2023 11:58am

HEM stock disappointment, outdated financial data

HEM'S lack of profitability and outdated financial data, investing in $HEM has been a frustrating experience.the company has consistently failed to turn a profit, leaving shareholders like me in a ...more  
152
Post by Jamesmachoon Oct 30, 2023 9:06am

The Ongoing Struggles of $HEM Stockholders

Investors in $HEM have faced a turbulent year, marked by a persistent downward trajectory in the stock price. This disappointing trend has left many questioning their investment decisions. The company ...more  
159
Post by ENEMENEMYNEMOon May 02, 2023 7:49pm

NCP

Great news for NCP...not so good for the sp...not even a blip!!!! What ever happened to the Canadian researcher that they collaborated with on this 2 years ago ?????? Why no word on that aspect ...more  
395
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse
Later
Participate
Not interested